Monocyte or white blood cell counts and β2 microglobulin predict the durable efficacy of daratumumab with lenalidomide.
Saved in:
| Title: | Monocyte or white blood cell counts and β2 microglobulin predict the durable efficacy of daratumumab with lenalidomide. |
|---|---|
| Authors: | Shimazu, Yutaka, Kanda, Junya, Kaneko, Hitomi, Imada, Kazunori, Yamamura, Ryosuke, Kosugi, Satoru, Shimura, Yuji, Ito, Tomoki, Fuchida, Shin-ichi, Uchiyama, Hitoji, Fukushima, Kentaro, Yoshihara, Satoshi, Hanamoto, Hitoshi, Tanaka, Hirokazu, Uoshima, Nobuhiko, Ohta, Kensuke, Yagi, Hideo, Shibayama, Hirohiko, Onda, Yoshiyuki, Tanaka, Yasuhiro, et al |
| Source: | Therapeutic advances in hematology 12/13/2022; Vol. 13. |
| Journal Info: | Publisher: Sage Publications Inc. ISSN: 2040-6207 |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2040-6215 |
|---|---|
| DOI: | 10.1177/20406207221142487 |
